News

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

RusNano to start production of vaccines and organogels

09-01-2012

Russia’s RusNano (Russian Corporation of Nanotechnologies) has signed an agreement with Russian…

Anti-viralsBiotechnologyCardio-vascularEpidbiomedEuropeFinancialMarkets & MarketingMergers & AcquisitionsNanolekOncologyRusNanoVaccines

Pfizer pencils JV deal with Hisun for low-cost generics in China; out-licenses drug to Clovis

03-06-2011

The world’s largest pharma company, USA-based Pfizer (NYSE: PFE), has entered into a memorandum…

Asia-PacificClovis OncologyGenericsMarkets & MarketingMergers & AcquisitionsOncologyPfizerPharmaceuticalResearchZhejiang Hisun Pharma

McKesson to acquire US Oncology in a deal valued at $2.16 billion

02-11-2010

One of the USA’s biggest drug distributor and health care services and information technology company,…

Markets & MarketingMcKessonMergers & AcquisitionsOncologyPharmaceuticalUS Oncology

Sanofi-Aventis debuts prostate cancer drug Jevtana in USA; Genzyme takeover still mooted

27-07-2010

Sanofi-Aventis recently announced the launch of its oncology drug, Jevtana (cabazitaxel), in the US.…

FinancialGenzymeMarkets & MarketingMergers & AcquisitionsOncologyPharmaceuticalSanofi-Aventis

COMPANY SPOTLIGHT

Menarini

Back to top